EuBiologics Co., Ltd. (KOSDAQ:206650)
South Korea · Delayed Price · Currency is KRW 13,100
-160 (-1.21%)
At close: Feb 6, 2026
EuBiologics Market Cap
EuBiologics has a market cap or net worth of 480.41 billion as of February 6, 2026. Its market cap has increased by 3.46% in one year.
Market Cap
480.41B
Enterprise Value
n/a
Revenue
96.04B
Ranking
n/a
PE Ratio
19.32
Stock Price
13,100.00
Market Cap Chart
Since January 24, 2017, EuBiologics's market cap has increased from 122.86B to 480.41B, an increase of 291.03%. That is a compound annual growth rate of 16.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 480.41B | 15.32% |
| Dec 30, 2025 | 416.60B | -6.15% |
| Dec 30, 2024 | 443.89B | 6.16% |
| Dec 28, 2023 | 418.14B | 28.91% |
| Dec 29, 2022 | 324.36B | -74.49% |
| Dec 30, 2021 | 1.27T | 93.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Jan 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dong-A Socio Holdings | 685.40B |
| Shinpoong Pharmaceutical Co.,Ltd | 660.83B |
| Huons Global | 622.35B |
| Dong-A ST | 511.97B |
| FutureChem Co.,Ltd | 503.38B |
| Humedix | 401.45B |
| Bukwang Pharmaceutical | 396.63B |
| Yungjin Pharm. | 339.27B |